Intel Corp vs Nuwellis Inc — how do they compare? Intel Corp trades at $98.64 (market cap $491.89B), while Nuwellis Inc trades at $1.5 (market cap $522.76K). The key difference: Intel Corp is far larger — about 940948× Nuwellis Inc's market cap, and Intel Corp pays a 2.24% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| INTC | NUWE | |
|---|---|---|
Market Cap | $491.89B | $522.76K |
Volume | 43,552,012 | — |
Sector | Technology | Technology |
52-Week High | $140.94 | $220.50 |
52-Week Low | $21.81 | $1.42 |
Enterprise Value | $512.70B | -$1.29M |
Dividend Yield | 2.24% | — |
Signals from Pluang's Aura AI — not financial advice
Intel (INTC) trades at $101.65, up 1.84% on the day, with a bullish technical signal from moving averages but a neutral oscillator stance. The company reported a net loss of $267 million in 2025 despite revenue of $52.85 billion, though it beat EPS estimates in recent quarters. Recent news highlights a $20 billion stock offering to fund AI expansion, causing short-term volatility but viewed as strategic for long-term growth.
Outlook is mixed: analyst consensus price target of $116.67 suggests upside, supported by AI investments, but high P/E of 904.17 and negative profit margins pose valuation risks. Key risks include intense competition, execution challenges in foundry growth, and reliance on capital raises amid cash burn in strategic segments.
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
Trailing returns across standard periods
Latest headlines on both assets
Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →